4 transcripts
VRNA
Earnings call transcript
NASDAQ
2024 Q2
8 Aug 24
on reimbursement? And how does that play into your strategy for the Ohtuvayre launch?
Edward, thank you for the question, and I appreciate that. Yes, I
VRNA
Earnings call transcript
NASDAQ
2024 Q1
9 May 24
continue to make excellent progress on our commercial launch preparation and are now finalizing key aspects, including sales force deployment strategy
VRNA
Earnings call transcript
NASDAQ
2023 Q4
29 Feb 24
position as we prepare to launch ensifentrine in the U.S. and advance new clinical programs.
Turning to our global partnering strategy. Our development
VRNA
Earnings call transcript
NASDAQ
2023 Q2
3 Aug 23
partnering strategy. In the second quarter, Nuance Pharma, our development partner in Greater China announced they enrolled the first subject
- Prev
- 1
- Next